The Economist features Welldoc and BlueStar®, our FDA-cleared digital health solution, in their Technology Quarterly edition on how digital health is rapidly becoming an integral part of health care.
Drug Delivery Business News features Welldoc’s latest data presented at ATTD 2022, evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control for individuals with Type 2 diabetes not treated with insulin.
FirstWord HealthTech reports on Welldoc’s latest data evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control.
Welldoc Presents Data Indicating Continuous Glucose Monitoring (CGM) Combined with a Digital Health Solution Leads to Significant Improvements in Glycemic Outcomes
COLUMBIA, Md., April 27, 2022 — Welldoc®, a digital health leader revolutionizing chronic care, today announced the presentation of data at the 15th International Conference on Advanced Technologies & Treatments for Diabetes …
Welldoc in the News: Columbia-based Welldoc Helps Patients Manage Diabetes, Hypertension and Heart Failure
The Baltimore Sun’s Howard County Magazine features Welldoc and Chief Strategy Officer, Anand Iyer.